122 related articles for article (PubMed ID: 32623389)
1. Screening and identification of key biomarkers in alimentary tract cancers: A bioinformatic analysis.
Cai Z; Wei Y; Chen S; Gong Y; Fu Y; Dai X; Zhou Y; Yang H; Tang L; Liu H
Cancer Biomark; 2020; 29(2):221-233. PubMed ID: 32623389
[TBL] [Abstract][Full Text] [Related]
2. Identifying the mRNAs associated with Bladder cancer recurrence.
Cao H; Cheng L; Yu J; Zhang Z; Luo Z; Chen D
Cancer Biomark; 2020; 28(4):429-437. PubMed ID: 32390597
[TBL] [Abstract][Full Text] [Related]
3. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
[TBL] [Abstract][Full Text] [Related]
4. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
Shang M; Zhang L; Chen X; Zheng S
Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
[TBL] [Abstract][Full Text] [Related]
5. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
[TBL] [Abstract][Full Text] [Related]
6. Identification of Hub Genes and Pathways in Gastric Adenocarcinoma Based on Bioinformatics Analysis.
Qiu J; Sun M; Wang Y; Chen B
Med Sci Monit; 2020 Feb; 26():e920261. PubMed ID: 32058995
[TBL] [Abstract][Full Text] [Related]
7. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
9. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
Zhang L; Sun L; Zhang B; Chen L
Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
[TBL] [Abstract][Full Text] [Related]
10. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.
Li L; Lei Q; Zhang S; Kong L; Qin B
Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457
[TBL] [Abstract][Full Text] [Related]
11. Cross‑validation of genes potentially associated with neoadjuvant chemotherapy and platinum‑based chemoresistance in epithelial ovarian carcinoma.
Zhang K; Wang W; Chen L; Liu Y; Hu J; Guo F; Tian W; Wang Y; Xue F
Oncol Rep; 2020 Sep; 44(3):909-926. PubMed ID: 32705213
[TBL] [Abstract][Full Text] [Related]
12. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
13. Identification of differentially expressed genes in pancreatic ductal adenocarcinoma and normal pancreatic tissues based on microarray datasets.
Liu L; Wang S; Cen C; Peng S; Chen Y; Li X; Diao N; Li Q; Ma L; Han P
Mol Med Rep; 2019 Aug; 20(2):1901-1914. PubMed ID: 31257501
[TBL] [Abstract][Full Text] [Related]
14. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analysis of potential core genes for glioblastoma.
Zhang Y; Yang X; Zhu XL; Hao JQ; Bai H; Xiao YC; Wang ZZ; Hao CY; Duan HB
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667033
[TBL] [Abstract][Full Text] [Related]
16. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract][Full Text] [Related]
17. An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer.
Yang ZQ; Liu YJ; Zhou XL
Med Sci Monit; 2020 Apr; 26():e921769. PubMed ID: 32235821
[TBL] [Abstract][Full Text] [Related]
18. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
[TBL] [Abstract][Full Text] [Related]
20. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
Li F; Guo P; Dong K; Guo P; Wang H; Lv X
J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
[No Abstract] [Full Text] [Related]
[Next] [New Search]
